14 Dec 2016 14:11
NMC Health plc
REVISED REMUNERATION POLICY - PUBLICATION OF CIRCULAR
London, 14 December 2016: NMC Health plc (NMC or the Company) (LSE: NMC), the leading integrated private healthcare provider operating across the United Arab Emirates, and one of the top global providers of fertility treatment, announces circulation of a notice to convene a General Meeting to consider the adoption of a new remuneration policy with related explanatory circular (the Circular).
The General Meeting (the GM) will be held on Thursday 29 December 2016 at 12:10 pm at the offices of Allen & Overy LLP, One Bishops Square, London E1 6AD. The Notice of Meeting with related explanatory circular and the associated Form of Proxy have today been published and posted to shareholders. A copy of the Circular and the accompanying Form of Proxy have also been submitted to the National Storage Mechanism and will shortly be available for inspection at www.Morningstar.co.uk/uk/NSM. In addition, the Circular will be available to view on the Company's website http://www.nmchealth.com/shareholder-information/ and available for inspection at the offices of Allen & Overy LLP, One Bishops Square, London E1 6AD.
Contacts:
Investors: |
|
NMC |
|
Simon Watkins, Group Company Secretary | +44 (0)20 3205 7313 |
|
|
Media: |
|
FTI Consulting, London |
|
Matthew Cole | +44 (0)20 3727 1101 |
FTI Consulting, Gulf |
|
Shane Dolan | +971 (0)4 437 2100 |
About NMC
NMC Health plc group is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The group currently operates or manages eight hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. In addition, NMC acquired a 51% shareholding in Fakih IVF Group, the Middle East market leader for in-vitro fertilisation (IVF) services. NMC also owns and operates Americare Group, the leading home care provider in the UAE as well as ProVita, the pioneering provider of long-term medical care, also in the UAE. The enlarged company received almost 3.2m patients in 2015. The group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. NMC Health plc group reported revenues of US$880.9m in 2015.
In April 2012 NMC Health plc was listed on the Premium Segment of the London Stock Exchange. NMC Health plc is a constituent of the FTSE 250 Index.